STERIS plc (Ireland) Ordinary Shares (STE) Company Bio
Steris Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The company was founded in 1985 and is based in Mentor, Ohio.
STE Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for STERIS plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that STERIS plc ranked in the 47th percentile in terms of potential gain offered. As for the metrics that stood out in our discounted cash flow analysis of STERIS plc, consider:
Interest coverage, a measure of earnings relative to interest payments, is 13.38; that's higher than 77.03% of US stocks in the Healthcare sector that have positive free cash flow.
The business' balance sheet suggests that 9% of the company's capital is sourced from debt; this is greater than merely 21.2% of the free cash flow producing stocks we're observing.
STE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 39.23% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as STE, try HRC, CNC, MEDP, DXCM, and AMGN.
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
Technavio has been monitoring the surgical drapes market and it is poised to grow by $ 536.73 mn during 2020-2024, progressing at a CAGR of about 3% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200624005627/en/ Technavio has announced its latest market research report titled Global Surgical Drapes Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Latest Free Sample Report on COVID-19 Impact The market is fragmented, and the degree ...
DUBLIN--(BUSINESS WIRE)--The "Medical Device Cleaning - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Medical Device Cleaning market accounted for $1.48 billion in 2019 and is expected to reach $3.14 billion by 2027 growing at a CAGR of 9.9% during the forecast period. Rising occurrence of acute diseases and regulatory requirements and compliance are the major factors driving market growth. However, increasing preference of the single